SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Clinical trials for SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA trials appear
Sign up with your email to follow new studies for SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Six-Drug cocktail tested for Hard-to-Treat brain lymphoma
Disease control OngoingThis study is testing a new combination of six drugs to treat aggressive B-cell lymphoma that has spread to the central nervous system (brain and spinal cord). The goal is to see if this combination is safe and effective at controlling the cancer and preventing it from getting wo…
Matched conditions: SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 20:26 UTC
-
Experimental Four-Target antibody tested for tough brain cancers
Disease control OngoingThis early-stage study is testing a new, four-target antibody drug called GNC-038 in adults with primary or secondary brain lymphoma that has come back or hasn't responded to other treatments. The main goals are to find a safe dose, understand how the body processes the drug, and…
Matched conditions: SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC